Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit (LATA)

December 26, 2019 updated by: University Hospital, Grenoble

Impact of a Written Document on Post Traumatic Stress Disorder (PTSD) Diagnosed in Family Members After Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit

Relatives of patients in situation of withholding and withdrawing life-sustaining therapies often show post traumatic stress disorder (PTSD) (60%)[1]. This number is even greater when family members are active in this decision (81%) or when communication is not optimal between medical team and family members.

There are several ways to assist families of patients in intensive care units [2], amongst them the use of a written document to explain the environment, therapies and possible outcomes.

Here the investigators want to test the impact of a written document in the context of end-of-life conference in intensive care units. Specifically, this research addresses wether such written support could decrease 3-months post-traumatic stress disorder, anxiety and depression exhibited by the closest family member or the patient representative.

Study Overview

Study Type

Interventional

Enrollment (Actual)

74

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Grenoble, France, 38043
        • Anesthesiology and Critical Care Depratment, Grenoble University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

The study will enroll patient representant (family member or close friends designed by the family or pre-admission legal representant).

Inclusion Criteria:

  • Medical team anticipates a decision to withhold and withdraw life-sustaining therapies to intensive care unit (ICU) discharge
  • verbal consent to participate
  • Able to communicate in French

Exclusion Criteria:

  • representant of a patient < 18 years old
  • representant of a patient whose stay in ICU lasted less than 48 hours
  • representant of a patient without social security

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Written document
Accompanying relatives with a written document when discussing withholding and withdrawing life-sustaining therapies . All other procedures are standard.
The document describes the law and the role of family members and medical team in the decision.
Active Comparator: Standard
Discussing withholding and withdrawing life-sustaining therapies following standard procedure without written document

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of PTSD
Time Frame: 3 months
PTSD is assessed with Impact Event Scale (IES) on the family representative
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of depression
Time Frame: 3 months
Depression is assessed with Hospital Anxiety and Depression scale (HADS) on the family representative
3 months
Rate of anxiety
Time Frame: 3 months
Anxiety is assessed with Hospital Anxiety and Depression scale (HADS) on the family representative
3 months
Mean level of HADS (anxiety and depression subscales)
Time Frame: 3 months
3 months
Mean level of IES
Time Frame: 3 months
3 months
Length of the processus from decision to withhold and withdraw life-sustaining therapies to intensive care unit (ICU) discharge
Time Frame: An average of 6 days
An average of 6 days
Respectfulness of the law regarding withholding and withdrawing life-sustaining therapies
Time Frame: An average of 6 days
An average of 6 days
Rate of decision to withhold and withdraw life-sustaining therapies in different intensive care units from the hospital
Time Frame: ICU discharge (an average of 3 weeks)
ICU discharge (an average of 3 weeks)
Medical Doctor satisfaction with the processus
Time Frame: ICU discharge (an average of 3 weeks)
ICU discharge (an average of 3 weeks)
Description of the processus
Time Frame: ICU discharge (an average of 3 weeks)
ICU discharge (an average of 3 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2014

Primary Completion (Actual)

October 1, 2017

Study Completion (Actual)

March 1, 2018

Study Registration Dates

First Submitted

December 29, 2014

First Submitted That Met QC Criteria

December 29, 2014

First Posted (Estimate)

December 31, 2014

Study Record Updates

Last Update Posted (Actual)

December 27, 2019

Last Update Submitted That Met QC Criteria

December 26, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Traumatic Stress Disorder

Subscribe